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Background: Metastases in the oral cavity are rare and account for only 1 to 3% of all malignant lesions in this 
area. The primary location from which most metastases have been described in the oral cavity in adult patients 
include lungs, breasts, kidneys and colon.
Material and Methods: A systematic search of the literature was carried out following the PRISMA statement in 
PubMed database. Clinical trials and case series published in the last 10 years [2010-2020] were eligible to be se-
lected. The headings and keywords used in the searches were “cancer” AND “oral metastases”, “incidence” AND 
“oral metastases”, “oral metastases” AND “jaw bone”, “oral metastases” AND “soft tissue”.
Results: For the study of the incidence of metastases in the oral cavity, 9 reports of clinical trials and 7 retrospec-
tive studies of case series have been included in this article. The primary locations from which more metastases 
have been described in the oral cavity are lungs (30.6% or 183 cases), breasts (22.2% or 133 cases), liver (15.5% 
or 93 cases), prostate (9 % or 54 cases), thyroid glands (8.1% or 49 cases), kidneys (7.3% or 44 cases), skin (2.3% 
or 14 cases), soft tissues (2% or 12 cases), colon (2% or 12 cases) and gastrointestinal (0.6% or 4 cases). These 
metastases have a predilection for hard tissues. The clinical presentation of these lesions varies from painless 
granulomatous lesions to lytic areas in the jaws.
Conclusions: Although metastases in the oral cavity is an uncommon pathology, early diagnosis is needed so that 
in the event that it is the first manifestation, it allows the primary tumor to be diagnosed as soon as possible.
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Introduction
Oral metastases is known to be a cancerous pathology 
that has its origin in another primary location from 
which it has spread. Tumors that metastasize in the oral 
region can, in many cases, be the secondary spread of 
another metastasis (1).
Metastases in the oral cavity are rare and account for 
only 1 to 3% of all malignant lesions in this area (1,2). 
These metastases have greater predilection for the jaws 
than for soft tissues and this has been reported in the 
literature (3). Specifically, of the maxillary bones, the 
mandible is the most frequently affected location. In 
soft tissues, the attached gingiva is the most common 
location for the settlement of metastases, followed by 
the tongue (4,5). It is believed that the dissemination 
mechanism of a neoplasm from the primary location to 
the oral cavity is basically through blood dissemination, 
through the epidural venous plexus (Batson venous sys-
tem), which vascularizes the axial skeleton and the head 
region and neck (6-8).
The primary location from which more metastases have 
been described in the oral cavity in adult patients in-
cludes lungs, breasts, kidneys and colon (1). Differences 
are found based on gender: for men, the most commonly 
reported location are the lungs, followed by prostate, 
liver and kidneys. On the other hand, in women, breasts 
are the primary location most associated with oral me-
tastases, followed by adrenal glands, tumors in the gen-
ital organs and colorectal organs (6,9).
Metastases treatment will vary depending on the prima-
ry tumor type and its spread degree, the patient overall 
health and tumor location (10). Management includes 
surgical resection, sometimes combined with radio 
or chemotherapy (3). In healthy patients who respond 
properly to primary tumor therapy, aggressive treat-
ment is recommended for oral metastases. However, if 
the primary tumor is recurrent and has other metasta-
ses, treatment of the oral lesion should be minimally 
invasive (11,12).
This type of metastases is a sign of widespread primary 
cancer and is a sign of poor prognosis, with 5-year sur-
vival rate below 5% (3,4,6,7).
In approximately 30% of patients with metastases in 
the jaw, the location of the primary tumor is unknown 
(10,12). This is the reason why knowing how to identify 
malignant lesions in the oral cavity is of great value, 
taking them into account in the differential diagnosis 
of inflammatory and reactive lesions, which are more 
common in this region. These lesions will require a bi-
opsy, which will confirm that it is a spread secondary 
lesion of another neoplasm coming from another organ.
This review aims to update the knowledge of the inci-
dence rate of metastases in the oral cavity and the pri-
mary tumors that cause them.
Material and Methods 
A systematic search of the literature was carried out fol-
lowing the PRISMA statement (“Preferred Reporting 
Items for Systematic Reviews and Meta-Analyzes”) in 
order to collect the greatest scientific evidence regard-
ing the incidence of oral cavity metastases (13).
The search strategy consisted of carrying out different 
bibliographic searches in the PubMed database without 
applying filters. The headings and keywords used in the 
searches were “cancer” AND “oral metastases”, “inci-
dence” AND “oral metastases”, “oral metastases” AND 
“jaw bone”, “oral metastases” AND “soft tissue”.
Those articles performed in humans that are clinical 
cases and case series, published in the last 10 years 
(2010 to 2020 period) were eligible to be selected. Stud-
ies published more than 10 years ago, that are not in 
Spanish or English, that are neither clinical cases nor 
clinical case series, as well as articles in which metasta-
ses does not occur in the oral cavity were excluded from 
this review.
Results
Fig. 1 flow chart exhibits the results of the initial lit-
erature search in PubMed. After discarding duplicate 
articles, 25 articles are left, of which we discarded 9 
because they do not meet the inclusion criteria.
Finally, for the study of the incidence rate of metasta-
ses in the oral cavity, 9 clinical cases (5,7,8,14-19) and 7 
retrospective studies of case series have been included 
in this article (Table 1) (2,4,12,20-23). From 609 tumors 
analyzed, 236 are in women (38.7%) and 373 are in men 
(61.2%), with a female/male distribution ratio of 0.63:1. 
In the clinical cases and case series studied, the mean 
age at the time of the oral metastases diagnosis is 62.1 
years (2,4,5,7,8,12,14-19,21-24).
From a geographical point of view, the cases included 
in the study are based in the first place on European 
populations such as the Italian, Croatian or French with 
10 case reports (2,5,7,8,12,14,17,20,24) followed by the 
United States (USA) with 2 cases (15,20) and finally 
countries such as Korea (21), Israel (4), India (17) and 
Brazil (18) of which only a single clinical case or case 
series has been included.
There are many possible locations of primary tumors 
but in our review the most reported are lungs (30.6% 
or 183 cases), followed by breasts neoplasms (22.2% or 
133 cases), liver (15.5 % or 93 cases), prostate (9% or 54 
cases), thyroid glands (8.1% or 49 cases), kidney (7.3% 
or 44 cases), skin (2.3% or 14 cases), soft tissues (2% or 
12 cases), colon (2% or 12 cases), gastrointestinal (0.6% 
or 4 cases). The tumors of which only 1 case has been 
reported in total in our review are rectum, esophagus, 
cervix, testicles and unknown origin (2,4,5,7,8,12,14-
19,21-24).
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19,21-24). Data collected from articles that meet the 
inclusion criteria except for the articles by Irani (22) 
and Liu et al. (20) have been included in Table 2. These 
two have not been included because they do not specify 
the data that is compared in the Table 2. Thus, Table 
2 shows data from 138 cases of primary tumors that 
produce metastases in the oral cavity, either in hard tis-
sues, in soft tissues or in both (2,4,5,7,8,12,14-19,21-24).
In order of frequency, the histopathological type of tu-
mors is: adenocarcinoma, squamous carcinoma, mela-
noma and sarcoma (2,4,5,7,8,12,14-19,21-24).
Prognosis of patients with metastases in the oral cavity 
is poor, with a mortality rate in this study close to 70%. 
Death occurs in a period of time ranging from 3 weeks 
after the diagnosis of metastases to 30 months, with a 
mean death at 9.81 months (2,4,5,7,8,12,14-19,21-24).
Regarding metastases in the oral cavity, they can occur 
in both hard and soft tissues, sometimes affecting both at 
the same time (Table 2). In this review, we demonstrated 
greater hard tissue involvement in women and greater 
soft tissue involvement in men. In addition, we can af-
firm that, in women, when the primary tumor is located 
in breasts, there is a greater involvement of the maxil-
lary bones compared to soft tissues. On the other hand, 
if the primary tumor is located in kidneys, lung, skin, 
or colorectal, the ones most affected tissues by metasta-
ses are the soft tissues. Regarding male gender, propor-
tions are different, being tumors such as lung, kidney, 
skin and soft tissues the ones that most metastasize in 
soft tissues of the oral cavity. In contrast, tumors lo-
cated in organs of the digestive system, liver or prostate, 
metastasize more often in hard tissues (2,4,5,7,8,12,14-
Fig. 1: PRISMA flow chart.
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Hard tissue in poste-
rior mandible None Lung adenocarcinoma
Exitus 12 
months
n: simple size. M: male. F: female. TMJ: Temporo-mandibular Joint. NE: not specified. HP: Histopathology. CR: Case Report. CS: Case Series
Table 1: Case reports and case series included in this review.
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Discussion
Tumor metastases in the oral cavity are uncommon, oc-
curring in 1-3% of cases (1,22). They usually appear as 
lesions in hard tissues of the maxilla and mandible, be-
ing the mandible the most frequent location (3,8,15,21). 
They can be lesions that originate in soft tissues and 
end up infiltrating bone or lesions that initially appear 
in hard tissues and end up resulting on soft tissues of the 
oral cavity (5,15,17,19).
Most of the patients diagnosed with metastases in the 
oral cavity are between the ages of 50 and 70 years old, 
although the age range can vary from 20 to 90 years old 
(1,4). Patients with metastases in the maxilla are usually 
younger than patients with soft tissue metastases, a re-
sult that is consistent with previous studies (6).
Predilection of metastases in the oral region for a par-
ticular gender is still considered controversial. Ac-
cording to the retrospective study by Lee et al. (21) in 
21 patients diagnosed with oral metastases, the female/
male ratio was 1:1.63, showing a predominance of the 
male gender. Same ratio occurs in the case series by 
Maschino et al. (23) where the ratio is 1:2.3 in favor of 
men. In our review, the female/male ratio is 0.63:1, so 
our data matches the majority of published literature 
regarding distribution by gender. On the other hand, in 
the case series published by Kaplan et al. (4), this ratio 
is 1.4:1, including 35 women and 25 men among their 
60 cases studied.
According to what has been reported, we could affirm 
that gender ratio is almost 1:1 when speaking of me-
tastases in the oral cavity, although location of metas-
tases in the oral region differs when we refer to men 
or women (25). Hirshberg et al. (6) reported in 2008 
that metastases in jaws have a predilection for females. 
However, according to another analysis of 390 cases, 
a predilection for the male sex was observed, both in 
metastases in the oral mucosa and those that occur in 
jaws (9). These patterns probably differ depending on 
factors such as race and age of the studied population, 
as well as the way to study these populations in differ-
ent research centers.
Different reviews of the literature studied confirm that 
primary tumors that most metastasize in the oral cav-
ity are those originating in breasts, lungs, kidneys and 
prostate (1,9,25). This review confirms that these ori-
gins are the most prevalent ones in terms of metastases 
in the oral region, but it should be noted that, as already 
discussed in previous studies, the nature of the primary 
tumor and the site of oral metastases have gender dif-
ferences (1,26). In women, primary cancers that most 
metastasize in the oral cavity are those originating in 
breasts, followed by kidneys, lung, skin and colorectal 
neoplasms. On the other hand, the order of frequency 
changes in men, being lungs the most frequent neo-
plasms, followed by kidneys and much less frequently 
liver, soft tissues such as sarcoma or those of unknown 
origin (1,26).
Distant metastases are the result of hematogenous 
spread. However, Baranovic et al. (16) described a 
colorectal adenocarcinoma with metastases in the liver 
and oral cavity, but without affecting lungs or peritone-
um, which are usually very common locations of metas-
tases for this type of carcinomas. This can be explained 
by Batson's theory (16), which considers that there are 4 
venous circuits: pulmonary, cava, portal and vertebral. 
In colorectal adenocarcinoma case, hematogenous dis-
Primary tumor location FEMALE MALESoft tissues Hard tissues Both Soft tissues Hard tissues Both
Breasts 7 12 3
Kidneys 5 4 8 5
Skin 4 3 2
Lungs 4 2 10 8 4
Colon-rectum 3 2 1 1
Gastrointestinal 3 2
Thyroid gland 1 2 1 1
Soft tissues (sarcoma) 5 3 1




Unknown 6 4 2
Others (pancreas, nostril, esophagus) 4
Total 29 36 4 36 26 7
Both: affects both hard and soft tissues.
Table 2: Distribution of the metastases in the oral cavity according to gender.
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semination through the vertebral circuit could occur, 
avoiding the neck and lungs region, thus producing 
oral metastases (16). It is considered that hard tissues 
metastases occur through hematogenous dissemina-
tion, being the mandible more frequently affected than 
the maxilla, probably due to the presence of terminal 
vascularization in the region and a greater presence of 
hematopoietic cells in the mandible, especially in the 
canines posterior region (8,21,27).
Clinical manifestations of oral metastases range from 
local pain or inflammation to paresthesia; therefore, 
its diagnosis is often complicated and delayed. They 
can be confused with pyogenic granulomas, giant cell 
granulomas, bone cysts, osteomyelitis or even with Pag-
et's disease, among many other differential diagnoses 
(6,25,27). Many patients report jaw inflammation with 
localized pain (17).
No specific signs were reported in the studied cases: 
ulcerated, inflamed or painful oral lesions, with a ten-
dency to bleeding or possible fistulization. Size, rapid 
growth, the tendency to bleed, necrotic appearance and/
or the possibility of recurrence of the lesion, as well as 
the general condition of the patient will help in reaching 
a diagnosis and subsequently, through the histopatho-
logical study, will reach the final diagnosis (2,21,23).
Histopathology of the primary tumor, in most cases, 
resembles or mimics that of metastases in the oral cav-
ity (8,17,25). Histological criteria for the diagnosis of a 
metastatic tumor are: a.- histopathology of the tumor 
must be verified primary, b.- metastatic tumor must be 
of the same subtype as the primary tumor and also, c.-
direct expansion due to continuity of the primary tumor 
must be excluded.
The prevalence of oral metastases has been linked to the 
incidence of primary cancers that appear in a certain 
population. There can be a lot of variation between dif-
ferent geographic areas according to the prevalence of a 
particular malignant tumor. For example, while in Spain 
breast cancer is the most prevalent among women, in 
India it is cancer of the uterine cervix. Data on primary 
tumors is more prevalent in a certain population having 
the possibility of causing metastases in the oral cavity. 
This will vary depending on the country from which 
a certain population has been studied (17). Moreover, 
variations in the incidence of the primary tumors lo-
cations may be due to several factors such as genetic 
mutations (4,8,25,28).
Metastases in the oral cavity can occur in hard tissues, 
but also in soft tissues. There are more cases of metas-
tases in hard tissues than in soft ones reported in the 
literature, being the alveolar mucosa and the tongue the 
most common locations when soft tissues are involved. 
For instance, tongue is more frequently involved be-
cause it is an organ rich in blood vessels where cells 
from the primary tumor can embolize (1,2).
Time in between oral metastases diagnostic and pa-
tient’s death varies from months to years, although the 
median survival ranges from 1 to 5 years. Both Hirsh-
berg et al. (6) and Van der Waal et al. (3) reported a 
mean survival of 6-7 months. In our review, of all the 
cases studied that end up in death, the mean survival 
is 9.81 months, with a range that varies from 3 weeks 
to 30 months. Only one case recovered 12 months after 
treatment and the rest are not specified.
Conclusions
It is important for the doctor/dentist to take into account 
oral metastases in the differential diagnosis of lesions 
in the oral cavity because, despite the fact that these are 
rare cases, they are a sign of widespread neoplasm, con-
ferring poor vital prognosis of the patient. The primary 
tumor sites that most metastasize to the oral cavity are 
the lung in both genders and breasts in females, closely 
followed by liver and kidneys also in both genders. Al-
though the majority of metastases in the oral cavity in-
clude jaws and gums, any location of the oral mucosa 
may be involved.
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